Mindray stock gained 1.45 percent on September 30 as H1 revenue rose

Published on 10/07/2026 at 09:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Mindray stock was trading at CNY 161.32 on Shenzhen on September 30, 2026, 35.2 percent below its 52-week high. First-half revenue rose 6.00 percent, while profit fell 5.37 percent.

Mindray, CNE100003G67, Illustration mit AI erstellt.

Mindray (ISIN CNE100003G67) was trading at CNY 161.32 on the Shenzhen Stock Exchange on September 30, 2026 at 3:04 p.m. CST, up CNY 2.31 or 1.45 percent from the prior close. As Futubull reported on September 30, 2026, the companys first-half results showed a return to revenue growth, but weaker attributable profit.

Revenue returns to growth

Revenue for the six months ended June 30, 2026, reached CNY 17.747 billion, an increase of 6.00 percent from the prior-year period, according to Futubull. Net profit attributable to shareholders declined 5.37 percent to CNY 4.797 billion, while second-quarter revenue rose 10.45 percent to CNY 9.395 billion.

The regional mix is shifting toward international markets. Overseas revenue increased 13.67 percent to CNY 9.471 billion in the first half and accounted for 53 percent of group revenue, while domestic revenue declined 1.61 percent to CNY 8.276 billion.

Emerging units outpace the group

Emerging businesses generated CNY 3.110 billion in first-half revenue, up 19.59 percent year over year, according to Futubull. That growth exceeded the companywide rate, but medical imaging revenue fell 5.78 percent to CNY 2.836 billion, showing that the recovery is uneven across product lines.

The main counterweight is profitability. The first-half report cited foreign-exchange losses of CNY 574 million in financial expenses, while medical equipment procurement and reagent price pressure also weighed on margins. The same Futubull report identified currency movements, IVD reagent price reductions and surgical-robot development as risks.

Consensus target exceeds CNY 280

Analyst expectations remain more constructive than the recent share price. Eulerpool lists 32 analysts in its consensus, with 30 Buy ratings, 2 Hold ratings and 0 Sell ratings. The average target is CNY 280.14, which lies 73.6 percent above the CNY 161.32 price on September 30, 2026.

Citic Securities maintained a Buy view in a September 30, 2026 assessment cited by Futubull. Its forecast put 2026 revenue at CNY 36.158 billion and net profit at CNY 8.204 billion, with profit growth of 0.8 percent. The gap between revenue and profit growth makes currency effects and margin recovery central to the next results update.

Mindray stock remains below its yearly high

Mindray stock was last at CNY 161.32 on the Shenzhen Stock Exchange on September 30, 2026 at 3:04 p.m. CST. The price stood 35.2 percent below the 52-week high of CNY 248.98 and above the low of CNY 130.66; market capitalization was CNY 195.6 billion and volume was 7,447,597 shares.